85
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Elevated High-Density Lipoprotein Cholesterol and Age-Related Macular Degeneration: The Alienor Study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Lipid metabolism and particularly high-density lipoprotein (HDL) may be involved in the pathogenic mechanism of age-related macular degeneration (AMD). However, conflicting results have been reported in the associations of AMD with plasma HDL and other lipids, which may be confounded by the recently reported associations of AMD with HDL-related genes. We explored the association of AMD with plasma lipid levels and lipid-lowering medication use, taking into account most of HDL-related genes associated with AMD.

          Methods

          The Alienor study is a population-based study on age-related eye diseases performed in 963 elderly residents of Bordeaux (France). AMD was graded from non mydriatic color retinal photographs in three exclusive stages: no AMD (n = 430 subjects, 938 eyes); large soft distinct drusen and/or large soft indistinct drusen and/or reticular drusen and/or pigmentary abnormalities (early AMD, n = 176, 247); late AMD (n = 40, 61). Associations of AMD with plasma lipids (HDL, total cholesterol (TC), Low-density lipoprotein (LDL), and triglycerides (TG)) were estimated using Generalized Estimating Equation logistic regressions. Statistical analyses included 646 subjects with complete data.

          Results

          After multivariate adjustment for age, sex, educational level, smoking, BMI, lipid-lowering medication use, cardiovascular disease and diabetes, and for all relevant genetic polymorphisms (ApoE2, ApoE4, CFH Y402H, ARMS2 A69S, LIPC rs10468017, LIPC rs493258 , LPL rs12678919, ABCA1 rs1883025 and CETP rs3764261), higher HDL was significantly associated with an increased risk of early (OR = 2.45, 95%CI: 1.54–3.90; P = 0.0002) and any AMD (OR = 2.29, 95%CI: 1.46–3.59; P = 0.0003). Association with late AMD was far from statistical significance (OR = 1.58, 95%CI: 0.48–5.17; p = 0.45). No associations were found for any stage of AMD with TC, LDL and TG levels, statin or fibrate drug use.

          Conclusions

          This study suggests that elderly patients with high HDL concentration may be at increased risk for AMD and, further, that HDL dysfunction might be implicated in AMD pathogenesis.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: not found

          Global data on visual impairment in the year 2002.

          This paper presents estimates of the prevalence of visual impairment and its causes in 2002, based on the best available evidence derived from recent studies. Estimates were determined from data on low vision and blindness as defined in the International statistical classification of diseases, injuries and causes of death, 10th revision. The number of people with visual impairment worldwide in 2002 was in excess of 161 million, of whom about 37 million were blind. The burden of visual impairment is not distributed uniformly throughout the world: the least developed regions carry the largest share. Visual impairment is also unequally distributed across age groups, being largely confined to adults 50 years of age and older. A distribution imbalance is also found with regard to gender throughout the world: females have a significantly higher risk of having visual impairment than males. Notwithstanding the progress in surgical intervention that has been made in many countries over the last few decades, cataract remains the leading cause of visual impairment in all regions of the world, except in the most developed countries. Other major causes of visual impairment are, in order of importance, glaucoma, age-related macular degeneration, diabetic retinopathy and trachoma.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of age-related macular degeneration in the United States.

            To estimate the prevalence and distribution of age-related macular degeneration (AMD) in the United States by age, race/ethnicity, and gender. Summary prevalence estimates of drusen 125 microm or larger, neovascular AMD, and geographic atrophy were prepared separately for black and white persons in 5-year age intervals starting at 40 years. The estimated rates were based on a meta-analysis of recent population-based studies in the United States, Australia, and Europe. These rates were applied to 2000 US Census data and to projected US population figures for 2020 to estimate the number of the US population with drusen and AMD. The overall prevalence of neovascular AMD and/or geographic atrophy in the US population 40 years and older is estimated to be 1.47% (95% confidence interval, 1.38%-1.55%), with 1.75 million citizens having AMD. The prevalence of AMD increased dramatically with age, with more than 15% of the white women older than 80 years having neovascular AMD and/or geographic atrophy. More than 7 million individuals had drusen measuring 125 microm or larger and were, therefore, at substantial risk of developing AMD. Owing to the rapidly aging population, the number of persons having AMD will increase by 50% to 2.95 million in 2020. Age-related macular degeneration was far more prevalent among white than among black persons. Age-related macular degeneration affects more than 1.75 million individuals in the United States. Owing to the rapid aging of the US population, this number will increase to almost 3 million by 2020.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

              A common detection and classification system is needed for epidemiologic studies of age-related maculopathy (ARM). Such a grading scheme for ARM is described in this paper. ARM is defined as a degenerative disorder in persons > or = 50 years of age characterized on grading of color fundus transparencies by the presence of the following abnormalities in the macular area: soft drusen > or = 63 microns, hyperpigmentation and/or hypopigmentation of the retinal pigment epithelium (RPE), RPE and associated neurosensory detachment, (peri)retinal hemorrhages, geographic atrophy of the RPE, or (peri)retinal fibrous scarring in the absence of other retinal (vascular) disorders. Visual acuity is not used to define the presence of ARM. Early ARM is defined as the presence of drusen and RPE pigmentary abnormalities described above; late ARM is similar to age-related macular degeneration (AMD) and includes dry AMD (geographic atrophy of the RPE in the absence of neovascular AMD) or neovascular AMD (RPE detachment, hemorrhages, and/or scars as described above). Methods to take and grade fundus transparencies are described.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2014
                7 March 2014
                : 9
                : 3
                : e90973
                Affiliations
                [1 ]Université de Bordeaux, Bordeaux, France
                [2 ]INSERM (Institut National de la Santé Et de la Recherche Médicale), ISPED (Institut de Santé Publique d’Épidémiologie et de Développement), Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
                [3 ]Centre Hospitalier Universitaire (CHU) de Bordeaux, Service d’Ophtalmologie, Bordeaux, France
                Massachusetts Eye & Ear Infirmary, Harvard Medical School, United States of America
                Author notes

                Competing Interests: ACG, none; JFK, Laboratoires Théa, Alcon, Allergan, Carl Zeiss Meditec, Bayer, Novartis; MND, Laboratoires Théa, Novartis; MBR, Allergan, Bausch Lomb, Laboratoires Théa, Biogen, Novartis; MLG, none; JFD, Novartis, IPSEN, Merck Serono, Lundbeck; PBG, Lesieur, Bausch & Lomb, Aprifel, Danone Institute, Canadian Association of Gerontology, the Jean Mayer Human Nutrition Research Center on Aging, Tufts University, Alzheimer’s Association, Groupe Lipides et Nutrition, Institut Pasteur, Conseil Régional d’Aquitaine, Vifor Pharma, Danone, Institut Carnot LISA and Groupe Lipides et Nutrition; CD, Laboratoires Théa, Bausch&Lomb, Novartis. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

                Conceived and designed the experiments: MND JFK MBR JFD PBG CD. Performed the experiments: MND JFK MBR JFD PBG CD. Analyzed the data: ACG MLG CD. Contributed reagents/materials/analysis tools: MND JFK MBR JFD PBG CD. Wrote the paper: ACG CD. Revised the manuscript for important intellectual content: MND JFK MBR MLG JFD PBG CD.

                Article
                PONE-D-13-40232
                10.1371/journal.pone.0090973
                3946623
                24608419
                86e3b8e7-d043-4d52-98f7-4501f5931299
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 1 October 2013
                : 5 February 2014
                Page count
                Pages: 11
                Funding
                Laboratoires Théa (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France), Laboratoires Théa participated in the design of the study, but no sponsor participated in the collection, management, statistical analysis and interpretation of the data, nor in the preparation, review or approval of the present manuscript.
                Categories
                Research Article
                Biology
                Biochemistry
                Lipids
                Lipid Metabolism
                Metabolism
                Lipid Metabolism
                Medicine
                Epidemiology
                Epidemiology of Aging
                Genetic Epidemiology
                Nutrition
                Ophthalmology
                Geriatric Ophthalmology
                Macular Disorders

                Uncategorized
                Uncategorized

                Comments

                Comment on this article